Medical Condition News

RSS

Fight CRC publishes manuscript investigating colon and rectal cancer in young adults

Fight Colorectal Cancer, the nation's largest advocacy organization dedicated to colon and rectal cancers announced today that the manuscript, "A summary of the Fight Colorectal Cancer working meeting: Exploring risk factors and etiology of sporadic early-age onset colorectal cancer" has been published in the August 2019 edition of Gastroenterology.

3 Aug 2019

Social contact could play an important role in staving off dementia

Being more socially active in your 50s and 60s predicts a lower risk of developing dementia later on, finds a new UCL-led study.

3 Aug 2019

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.

3 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

New model predicts cognitive decline of patients at risk for Alzheimer’s disease

A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.

2 Aug 2019

New stem cell combination may help repair damage caused by heart attack

A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF) and published in Nature Biotechnology.

2 Aug 2019

Study shows new treatment option for heart failure fluid overload

Higher doses of spironolactone, a diuretic (water pill), can prevent the need for dialysis in selected heart failure patients, a UT Health San Antonio study found.

2 Aug 2019

Scientist wins two-year grant for diagnosis of Alzheimer's, Parkinson's via innovative skin test

Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.

2 Aug 2019

Scientists discover rare genetic variants associated with epilepsy in large-scale study

For the first time, scientists have mapped out the genes associated with epilepsy.

2 Aug 2019

Yellow-lens glasses do not improve night driving visibility, study finds

A new study has found no evidence to support claims that yellow-lens anti-glare driving glasses improve night-time road visibility.

2 Aug 2019

Sesame could be added to the list of allergens on food packaging

Following a recent investigation, the FDA is considering taking regulatory action to ensure sesame is labeled as an allergen on food packaging.

2 Aug 2019

Increased sweating after trauma may predict PTSD risk

Within four hours of a traumatic experience, certain physiological markers namely, sweating are higher in people who go on to develop posttraumatic stress disorder (PTSD), according to a new study by a researcher at Case Western Reserve University and other institutions.

2 Aug 2019

Edinburgh has highest known rates of inflammatory bowel disease

Edinburgh has some of the highest known rates of inflammatory bowel disease in the world and the figure is expected to rise in the next 10 years.

2 Aug 2019

Blood test may accurately identify people with early Alzheimer's brain changes

Up to two decades before people develop the characteristic memory loss and confusion of Alzheimer's disease, damaging clumps of protein start to build up in their brains.

2 Aug 2019

Discovery of distinct lung cancer pathways could help future patients

Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute.

2 Aug 2019

Nurse-directed initiative results in sustained reduction of hypoglycemia

A nurse-directed initiative to examine the root causes of hypoglycemic episodes resulted in a sustained reduction in hypoglycemia among critically ill patients at Stamford Hospital in Connecticut, according to a study published in the August issue of Critical Care Nurse.

2 Aug 2019

HIV-infected elderly cancer patients have worse outcomes despite treatment

Elderly cancer patients who are HIV-positive, particularly those with prostate and breast cancers, have worse outcomes compared to cancer patients in the same age range who do not have HIV.

2 Aug 2019

Probiotics for kidney disorders to be showcased at ANNA 2019 in Dallas

Kibow Biotech, Inc., Pennsylvania, will feature its product for Kidney Illness, RENADYL™, at the 50th Anniversary Meeting of the American Nephrology Nurse Association (ANNA) in Dallas, Texas, USA.

From Kibow Biotech Inc. 2 Aug 2019

Company expands development plans for drugs which slow progression to dialysis

Kibow Biotech announces that the focus on supporting and maintaining healthy kidney function with probiotics/prebiotics to potentially delay the progression to dialysis is based on its enteric toxin reduction platform technology termed "Enteric Dialysis®"

From Kibow Biotech Inc. 2 Aug 2019

Research reveals potential target for therapies to prevent severe allergic reactions

Allergies can be life-threatening when they cause anaphylaxis, an extreme reaction with constriction of the airways and a sudden drop in blood pressure.

2 Aug 2019